Grant receipients focused on  Other Pediatric Cancers 

Lai Man (Natalie) Wu , PhD

Cincinnati Children’s Hospital Medical Center

Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Supported in part by Hanna's Hoops 4 Healing

Julien Fleurence PhD, PharmD

Baylor College of Medicine

T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers

Joanna Gell, md

University of California Los Angeles

Utilizing Pluripotent Stem Cells to Evaluate the Role KIT and KRAS Play in Germ Cell Development and Tumorigenesis

Kathryn Lemberg, md, phd

Johns Hopkins University - School of Medicine

Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors

Andras Heczey, M.D.

Texas Children's Hospital, Baylor College of Medicine

Glypican-3 specific T-cells for the adoptive immunotherapy of pediatric liver cancers

Ying Zhang, PhD

Mayo Clinic

The role of the de-ubiquitinase USP44 in childhood germ cell tumorigenesis

Monica Thakar, MD

Children's Hospital of Wisconsin, Medical College of Wisconsin

A Phase I/II Trial Evaluating NK Cell Immunotherapy in Relapsed and Refractory Pediatric Solid Tumors

Chungling Yi, PhD

Lombardi Cancer Center at Georgetown University

Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer

Holly Meany, MD

Children's National Medical Center

Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors

Kevin Jones, MD

University of Utah

Role of MITF in Clear Cell Sarcomagenesis